| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 16,980 | $30 | $577.1K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 109,800 | $1 | $439.2K |
| J9312 | Injection, rituximab, 10 mg | 7,400 | $60 | $436.6K |
| J0897 | Injection, denosumab, 1 mg | 11,280 | $20 | $203.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,400 | $90 | $129.8K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,700 | $30 | $92.5K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 9,020 | $10 | $81.1K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 1,040 | $60 | $57.3K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 6,930 | $10 | $55.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 510 | $100 | $51.4K |